Safety and Efficacy of Early Treatment With Deferiprone in Infants and Young Children

PHASE4CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 9, 2018

Primary Completion Date

September 29, 2020

Study Completion Date

September 29, 2020

Conditions

Beta Thalassemia Major AnemiaIron Overload

Interventions

DRUG

Deferiprone oral solution

Liquid formulation of deferiprone, with a concentration of 80 mg/mL

DRUG

Placebo

Liquid solution that matches deferiprone oral solution in appearance and taste

Trial Locations (4)

Ain Shams University Children's Hospital, Cairo

Pediatric Hospital of Cairo University, Cairo

The Clinical Research Center, Faculty of Medicine, Cairo University, Cairo

Cipto Mangunkusumo National Hospital, Jakarta

All Listed Sponsors

lead

Chiesi Canada Corp

INDUSTRY

NCT03591575 - Safety and Efficacy of Early Treatment With Deferiprone in Infants and Young Children | Biotech Hunter | Biotech Hunter